Rebekah leads VentureWell’s Commercialization programmatic advancements in the health sector, including VentureWell’s role as the Investor Catalyst Hub for ARPA-H and participation in the NIH Rapid Acceleration of Diagnostics (RADx®) initiative. She also provides support and expertise across VentureWell’s biomedical engineering– and medical technology–focused programs. Prior to VentureWell, Rebekah managed a portfolio of investments in discovery science, technology, and innovation ecosystem development, focused on early-stage innovation and innovators as a program officer at the Bill & Melinda Gates Foundation. Rebekah holds a Ph.D. in Biomedical Engineering from the University of Virginia and a B.S. in Biomedical Engineering from Georgia Tech.